Abstract
Context:
Insulin resistance precedes metabolic syndrome abnormalities and may promote cardiovascular disease and type 2 diabetes in children with obesity. Results of lifestyle modification programs have been discouraging, and the use of adjuvant strategies has been necessary.
Objective:
This study aimed to evaluate the effects of metformin and conjugated linoleic acid (CLA) on insulin sensitivity, measured via euglycemic-hyperinsulinemic clamp technique and insulin pathway expression molecules in muscle biopsies of children with obesity.
Design:
A randomized, double-blinded placebo-controlled clinical trial was conducted.
Setting:
Children and adolescents with obesity were randomly assigned to receive either metformin, CLA or placebo (PLB). (Clinicaltrials.gov:NCT02063802)
Main outcome measures: Results:
Intervention had a positive effect on weight, height, BMI, waist circumference, and fitness condition in all groups. For the primary outcome, Insulin Sensitivity Rd-value (mg/kg/min), there was a statistically significant difference between the CLA group compared to PLB (6.53±2.54 Vs 5.05±1.46, p=0.035). Fasting insulinemia and HOMA-IR significantly improved in the CLA group (p=0.045). Analysis of covariance was conducted to control the influence of BMI, BMI change, age, Tanner stage, prescribed diet, and fitness achievement over the Insulin Sensitivity Rd-value. Tanner stage showed a statistically significant influence. Nonetheless, a clinically relevant effect size on insulin sensitivity was evident in the CLA-treated patients (37%) that exceeded lifestyle intervention program benefits. Moreover, up regulated expression of the Insulin Receptor Substrate 2 (IRS-2) was evident in muscle biopsies of CLA treated children.
Conclusions:
Improvement of insulin sensitivity, measured via euglycemic- hyperinsulinemic clamp and IRS2 up regulation, favored patients treated with CLA.
http://press.endocrine.org/doi/abs/10.1210/jc.2016-2701
Context:
Insulin resistance precedes metabolic syndrome abnormalities and may promote cardiovascular disease and type 2 diabetes in children with obesity. Results of lifestyle modification programs have been discouraging, and the use of adjuvant strategies has been necessary.
Objective:
This study aimed to evaluate the effects of metformin and conjugated linoleic acid (CLA) on insulin sensitivity, measured via euglycemic-hyperinsulinemic clamp technique and insulin pathway expression molecules in muscle biopsies of children with obesity.
Design:
A randomized, double-blinded placebo-controlled clinical trial was conducted.
Setting:
Children and adolescents with obesity were randomly assigned to receive either metformin, CLA or placebo (PLB). (Clinicaltrials.gov:NCT02063802)
Main outcome measures: Results:
Intervention had a positive effect on weight, height, BMI, waist circumference, and fitness condition in all groups. For the primary outcome, Insulin Sensitivity Rd-value (mg/kg/min), there was a statistically significant difference between the CLA group compared to PLB (6.53±2.54 Vs 5.05±1.46, p=0.035). Fasting insulinemia and HOMA-IR significantly improved in the CLA group (p=0.045). Analysis of covariance was conducted to control the influence of BMI, BMI change, age, Tanner stage, prescribed diet, and fitness achievement over the Insulin Sensitivity Rd-value. Tanner stage showed a statistically significant influence. Nonetheless, a clinically relevant effect size on insulin sensitivity was evident in the CLA-treated patients (37%) that exceeded lifestyle intervention program benefits. Moreover, up regulated expression of the Insulin Receptor Substrate 2 (IRS-2) was evident in muscle biopsies of CLA treated children.
Conclusions:
Improvement of insulin sensitivity, measured via euglycemic- hyperinsulinemic clamp and IRS2 up regulation, favored patients treated with CLA.
http://press.endocrine.org/doi/abs/10.1210/jc.2016-2701